Xu C, Sun J, Liang Q, Zhao H, et al. Conversion surgery as a missing outcome in first-line immunotherapy trials for hepatocellular carcinoma: Conversion surgery in HCC immunotherapy. J Hepatol 2026 Feb 18:S0168-8278(26)00025-5. doi: 10.1016/j.jhep.2026.
PMID: 41720196